Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 8 min ago
Peer-reviewedLicence not statedChemistry and Biology

Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions

  • Eduard Badarau
  • Zhuo Wang
  • Dan Rathbone
  • Andrea Costanzi
  • Thomas Thibault
  • Colin Murdoch
  • Said El Alaoui
  • Milda Bartkeviciute
  • Martin Griffin
Open at sourceDOICite

Related

  1. Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors
    Eduard Badarau, Alexandre Mongeot, Russell Collighan +2
    European Journal of Medicinal ChemistryPeer-reviewedLicence not stated21 citedMolecular biology & gene regulationHAL
  2. Biochemical Characteristics of the Vascular Microenvironment in Pathological Conditions and Precision Therapeutic Strategies
    LI Bo-Chao
    Shengwu huaxue yu shengwu wuli jinzhanPeer-reviewedCC BY-NCFull textMolecular biology & gene regulationDOAJ
  3. Ctcf deficiency in myofibers induces pathological genome reprogramming toward the spontaneous development of myopathy
    J. Massenet, C. Nicoletti, L. Caputo +11
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationbioRxiv
  4. Transglutaminase 3 is a Histone Monoaminylation Writer
    Yvonne Ritsema, Huapeng Li, Xingyu Ma +2
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationbioRxivPMC
  5. Development of next-generation ALDH1B1 inhibitors with enhanced pharmacological and functional properties
    A. Kaan Tarhan, Zhiping Feng, Daniel Fernandez +7
    Journal of medicinal chemistryPeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationPMC

Cite

BibTeXRIS
BibTeX
@article{badarau2026development,
  title = {{Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions}},
  author = {Eduard Badarau and Zhuo Wang and Dan Rathbone and Andrea Costanzi and Thomas Thibault and Colin Murdoch and Said El Alaoui and Milda Bartkeviciute and Martin Griffin},
  journal = {Chemistry and Biology},
  year = {2026},
  month = oct,
  doi = {10.1016/j.chembiol.2015.08.013},
  url = {https://hal.science/hal-05793298v1},
}
RIS
TY  - JOUR
TI  - Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions
AU  - Eduard Badarau
AU  - Zhuo Wang
AU  - Dan Rathbone
AU  - Andrea Costanzi
AU  - Thomas Thibault
AU  - Colin Murdoch
AU  - Said El Alaoui
AU  - Milda Bartkeviciute
AU  - Martin Griffin
PY  - 2026
DA  - 2026/10/12
JO  - Chemistry and Biology
DO  - 10.1016/j.chembiol.2015.08.013
UR  - https://hal.science/hal-05793298v1
SN  - 1074-5521
SN  - 1879-1301
ER  -